The scope of the present review is to discuss the prognosis of diabetic renal disease, putative progression promoters and the possibilities for treatment and prediction of treatment efficacy. The recent changes in the incidence of diabetic nephropathy in Type 1 diabetes mellitus are discussed. Promo
The potential of multimer technologies in type 1 diabetes prediction strategies
โ Scribed by Alessandra Fierabracci
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 182 KB
- Volume
- 27
- Category
- Article
- ISSN
- 1520-7552
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Type 1 diabetes is a disease characterised by disturbed glucose homeostasis, which results from autoimmune destruction of the insulinโproducing beta cells in the pancreas. The autoimmune attack, while not yet fully characterised, exhibits components of both misโtargeting and failed tole
The prodromal phase of type 1 diabetes is characterised by the appearance of multiple islet-cell related autoantibodies (Aab). The major target antigens are islet-cell antigen, glutamic acid decarboxylase (GAD), protein-tyrosine phosphatase-2 (IA-2) and insulin. Insulin autoantibodies (IAA), in cont
Background Type 1 diabetes (T1D) is a clinically heterogeneous disease. The presence of associated autoimmune diseases (AAIDs) may represent a distinct form of autoimmune diabetes, with involvement of specific mechanisms. The aim of this study was to find predictors of AAIDs in the Type 1 Diabetes G